← 홈

폐암 (NSCLC)

291개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 291개
CGTBiologicstaleIntima Bioscience, Inc.Phase 2

CISH Inactivated TIL (CISH Inactivated TIL)

Carcinoma, Non-Small-Cell Lung; Metastatic Non Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 2상태 DISCONTINUED
CGTBiologicGuangzhou Bio-gene Technology C…Phase 1

CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells (CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells)

Non Small Cell Lung Cancer · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
AntibodystaleAbbViePhase 1

Cofetuzumab Pelidotin (Cofetuzumab Pelidotin)

Cancer; Non-small Cell Lung Cancer (NSCLC) · Cancer

#Cancer#Antibody#Phase1#항체#면역항체+3
임상시험 2상태 DISCONTINUED
ADCBiologicstaleEnliven TherapeuticsPhase 1

ELVN-002 (ELVN-002)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleRochePreclinical

atezolizumab (Tecentriq, First line EC/EP+Atezolizumab)

Extensive Stage Small Cell Lung Cancer · Extensive Stage Small Cell Lung Cancer

#ExtensiveStageSmallCellLungCance#Antibody#Preclinical#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleEli Lilly and CompanyPhase 2

cixutumumab (IMC-A12, IMC-A12 (cixutumumab))

Non-Small Cell Lung Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 37.9%임상시험 2상태 ACTIVE
AntibodystaleRoswell Park Cancer InstitutePhase 1

Nimotuzumab (Nimotuzumab)

EGFR Gene Mutation; Recurrent Non-Small Cell Lung Carcinoma · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#항체#면역항체+4
임상시험 2상태 ACTIVE
ADCBiologicstalePfizerPhase 3

PF-08046054 (PF-08046054)

Non-small Cell Carcinoma; Non-Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

#Non-smallCellCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 1

SEA-TGT (SEA-TGT)

Non-small Cell Lung Cancer; Gastric Carcinoma · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 33.3%임상시험 2상태 DISCONTINUED
AntibodystaleBeiGenePhase 2

atezolizumab (Tecentriq, Tislelizumab/Atezolizumab/ Durvalumab/Benmelstobart/Toripalimab/Serplulimab)

Extensive Stage Lung Small Cell Cancer · Extensive Stage Lung Small Cell Cancer

#ExtensiveStageLungSmallCellCance#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
AntibodystaleXencor, Inc.Phase 2

XmAb18087 (XmAb18087)

Merkel Cell Carcinoma; Small Cell Lung Cancer · Merkel Cell Carcinoma

#MerkelCellCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 DISCONTINUED
CGTBiologicstaleInge Marie SvanePhase 2

Young TIL (Young TIL)

Metastatic Colorectal Cancer; Metastatic Pancreatic Cancer · Advanced Non-Small Cell Lung Cancer

#AdvancedNon-SmallCellLungCancer#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 33.3%임상시험 2상태 RECRUITING
CGTBiologicstaleShanghai Cell Therapy Group Co.…Phase 1

αPD1-MSLN-CAR T cells (αPD1-MSLN-CAR T cells)

Colorectal Cancer; Ovarian Cancer · Non-small-cell Lung Cancer

#Non-small-cellLungCancer#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 ACTIVE
ADCBiologicstale3H Pharmaceuticals Co., Ltd.Phase 2

3H-10000 (3H-10000)

Lung Cancer; Stomach Cancer · Lung Cancer

#LungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleThe Netherlands Cancer InstitutePhase 2

89Zr-Patritumab deruxtecan (89Zr-Patritumab deruxtecan)

Non-Small Cell Lung Carcinoma; Advanced Non-Small Cell Squamous Lung Cancer · EGFR

#EGFR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, 89Zr-Pembrolizumab)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleAbbViePhase 1

ABBV-221 (ABBV-221)

Head and Neck Squamous Cell Carcinoma; Non-small Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleAlentis Therapeutics AGPhase 2

ALE.P02 (ALE.P02)

Squamous Non-small-cell Lung Cancer; Head and Neck Squamous Cell Carcinoma · Squamous Non-small-cell Lung Cancer

#SquamousNon-small-cellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleAlentis Therapeutics AGPhase 2

ALE.P03 (ALE.P03)

Cervical Squamous Cell Carcinoma; Squamous Non-small-cell Lung Cancer · Cervical Squamous Cell Carcinoma

#CervicalSquamousCellCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 1

ALK-inhibitor or RET-inhibitor (ALK-inhibitor or RET-inhibitor)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING

6 / 15 페이지

← 이전다음 →